December 2023 Erie Insurance Company of New York
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
ASSETS
|
Current Year |
Prior Year |
||||||||
|
1 |
2 |
3 |
4 |
||||||
|
Net Admitted Assets |
Net Admitted |
||||||||
|
Assets |
Nonadmitted Assets |
(Cols. 1 - 2) |
Assets |
||||||
|
1. |
Bonds (Schedule D) |
68,992,508 |
................................... |
68,992,508 |
72,445,713 |
||||
|
2. |
Stocks (Schedule D): |
||||||||
|
2.1 Preferred stocks |
................................... |
................................... |
................................... |
................................... |
|||||
|
2.2 Common stocks |
34,218 |
................................... |
34,218 |
38,106 |
|||||
|
3. |
Mortgage loans on real estate (Schedule B): |
||||||||
|
3.1 First liens |
................................... |
................................... |
................................... |
................................... |
|||||
|
3.2 Other than first liens |
................................... |
................................... |
................................... |
................................... |
|||||
|
4. |
Real estate (Schedule A): |
||||||||
|
4.1 Properties occupied by the company (less $ |
|||||||||
|
encumbrances) |
................................... |
................................... |
................................... |
................................... |
|||||
|
4.2 Properties held for |
the production of income (less |
||||||||
|
$ |
encumbrances) |
................................... |
................................... |
................................... |
................................... |
||||
|
4.3 Properties held for sale (less $ |
|||||||||
|
encumbrances) |
................................... |
................................... |
................................... |
................................... |
|||||
|
5. |
Cash ($ ........................ (9,813) , Schedule E - Part 1), cash equivalents |
||||||||
|
($ |
...................2,104,220 |
, Schedule E - Part 2) and short-term |
|||||||
|
investments ($ |
, Schedule DA) |
2,094,407 |
................................... |
2,094,407 |
2,028,706 |
||||
|
6. |
Contract loans (including $ |
................................... premium notes) |
................................... |
................................... |
................................... |
................................... |
|||
|
7. |
Derivatives (Schedule DB) |
................................... |
................................... |
................................... |
................................... |
||||
|
8. |
Other invested assets (Schedule BA) |
................................... |
................................... |
................................... |
................................... |
||||
|
9. |
Receivable for securities |
192,541 |
................................... |
192,541 |
247,394 |
||||
|
10. |
Securities lending reinvested collateral assets (Schedule DL) |
................................... |
................................... |
................................... |
................................... |
||||
|
11. |
Aggregate write-ins for invested assets |
................................... |
................................... |
................................... |
................................... |
||||
|
12. |
Subtotals, cash and invested assets (Lines 1 to 11) |
71,313,674 |
................................... |
71,313,674 |
74,759,919 |
||||
|
13. |
Title plants less $ |
charged off (for Title insurers |
|||||||
|
..............................................................................................................only) |
................................... |
................................... |
................................... |
................................... |
|||||
|
14. |
.............................................................Investment income due and accrued |
...................... 689,939 |
................................... |
...................... 689,939 |
...................... 695,630 |
||||
|
15. |
Premiums and considerations: |
||||||||
|
15.1 Uncollected premiums and agents' balances in the course of collection |
5,376,044 |
114,206 |
5,261,838 |
5,205,748 |
|||||
|
15.2 Deferred premiums, agents' balances and installments booked but |
|||||||||
|
...................................deferred and not yet due (including $ |
|||||||||
|
............................................................earned but unbilled premiums) |
................. 76,571,105 |
................................... |
................. 76,571,105 |
................. 59,506,854 |
|||||
|
...................................15.3 Accrued retrospective premiums ($ |
) and |
||||||||
|
contracts subject to redetermination ($ |
) |
................................... ................................... ................................... ................................... |
16. Reinsurance:
|
....................................................16.1 Amounts recoverable from reinsurers |
........................ 14,489 |
................................... |
........................ 14,489 |
........................ 11,464 |
||
|
..........................16.2 Funds held by or deposited with reinsured companies |
........................ 45,574 |
................................... |
........................ 45,574 |
........................ 53,612 |
||
|
........................16.3 Other amounts receivable under reinsurance contracts |
..........................1,025 |
................................... |
..........................1,025 |
..........................2,114 |
||
|
17. |
Amounts receivable relating to uninsured plans |
................................... |
................................... |
................................... |
................................... |
|
|
18.1 |
Current federal and foreign income tax recoverable and interest thereon .... |
................... 1,789,547 |
................................... |
................... 1,789,547 |
...................1,301,989 |
|
|
18.2 |
Net deferred tax asset |
...................... 808,078 |
................................... |
...................... 808,078 |
...................... 603,585 |
|
|
19. |
......................................................Guaranty funds receivable or on deposit |
................................... |
................................... |
................................... |
................................... |
|
|
20. |
.....................................Electronic data processing equipment and software |
................................... |
................................... |
................................... |
................................... |
|
|
21. |
Furniture and equipment, including health care delivery assets |
|||||
|
($ |
) |
........................ 70,924 |
........................ 70,924 |
................................... |
................................... |
|
|
22. |
.........Net adjustment in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
................................... |
................................... |
|
|
23. |
.....................................Receivables from parent, subsidiaries and affiliates |
................................... |
................................... |
................................... |
................................... |
|
|
24. |
Health care ($ |
) and other amounts receivable |
................................... |
................................... |
................................... |
................................... |
|
25. |
Aggregate write-ins for other than invested assets |
.......................273,609 |
........................ 35,679 |
.......................237,930 |
.......................322,780 |
|
|
26. |
Total assets excluding Separate Accounts, Segregated Accounts and |
|||||
|
Protected Cell Accounts (Lines 12 to 25) |
............... 156,954,008 |
...................... 220,809 |
................156,733,199 |
................142,463,695 |
||
|
27. |
From Separate Accounts, Segregated Accounts and Protected Cell |
|||||
|
Accounts |
................................... |
................................... |
................................... |
................................... |
||
|
28. |
Total (Lines 26 and 27) |
156,954,008 |
220,809 |
156,733,199 |
142,463,695 |
|
|
DETAILS OF WRITE-INS |
||||||
|
1101 |
.................................... |
.................................... |
.................................... |
.................................... |
|
|
1102 |
.................................... |
.................................... |
.................................... |
.................................... |
|
|
1103 |
.................................... |
.................................... |
.................................... |
.................................... |
|
|
1198. |
Summary of remaining write-ins for Line 11 from overflow page |
................................... |
................................... |
................................... |
................................... |
|
1199. |
Totals (Lines 1101 thru 1103 plus 1198)(Line 11 above) |
||||
|
2501. |
Equity and Deposits in |
2,469 |
................................... |
2,469 |
5,455 |
|
2502. |
Premium Tax Credits & Other |
...................... 219,557 |
........................ 35,679 |
.......................183,878 |
...................... 176,415 |
|
2503. |
Other Accounts Receivable |
........................ 51,583 |
................................... |
........................ 51,583 |
..........................1,078 |
|
2598. |
Summary of remaining write-ins for Line 25 from overflow page |
................................... |
................................... |
................................... |
.......................139,832 |
|
2599. |
Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) |
273,609 |
35,679 |
237,930 |
322,780 |
2
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
LIABILITIES, SURPLUS AND OTHER FUNDS
|
1 |
2 |
||||
|
Current Year |
Prior Year |
||||
|
1. |
Losses (Part 2A, Line 35, Column 8) |
........................................................................................................................................ |
................. 31,154,026 |
................. 27,439,197 |
|
|
2. |
.....................................Reinsurance payable on paid losses and loss adjustment expenses (Schedule F, Part 1, Column 6) |
................................... |
................................... |
||
|
3. |
.........................................................................................................Loss adjustment expenses (Part 2A, Line 35, Column 9) |
................... 4,570,385 |
................... 4,352,287 |
||
|
4. |
.............................................................................Commissions payable, contingent commissions and other similar charges |
................................... |
................................... |
||
|
5. |
...............................................................................................................Other expenses (excluding taxes, licenses and fees) |
................................... |
..........................4,811 |
||
|
6. |
...................................................................................Taxes, licenses and fees (excluding federal and foreign income taxes) |
.......................396,344 |
...................... 260,120 |
||
|
7.1 |
...................................Current federal and foreign income taxes (including $ |
on realized capital gains (losses)) |
................................... |
................................... |
|
|
7.2 |
Net deferred tax liability |
................................... |
................................... |
||
|
8. |
Borrowed money $ |
and interest thereon $ |
.......................................... |
................................... |
................................... |
9. Unearned premiums (Part 1A, Line 38, Column 5) (after deducting unearned premiums for ceded reinsurance of
|
$ |
121,314,711 |
and including warranty reserves of $ |
and accrued accident and |
||||
|
health experience rating refunds including $ |
for |
medical loss ratio rebate per the Public Health |
|||||
|
.............................................................................................................................................................................Service Act) |
................. 22,053,763 |
................. 18,521,723 |
|||||
|
10. |
.....................................................................................................................................................................Advance premium |
.......................425,713 |
.......................387,622 |
||||
|
11. |
Dividends declared and unpaid: |
||||||
|
......................................................................................................................................................................11.1 Stockholders |
................................... |
................................... |
|||||
|
.....................................................................................................................................................................11.2 Policyholders |
........................ 34,348 |
........................ 42,597 |
|||||
|
12. |
........................................................................................Ceded reinsurance premiums payable (net of ceding commissions) |
................. 69,212,461 |
................. 53,626,452 |
||||
|
13. |
Funds held by company under reinsurance treaties (Schedule F, Part 3, Column 20) |
............................................................. |
................................... |
................................... |
|||
|
14. |
Amounts withheld or retained by company for account of others |
.............................................................................................. |
.......................173,742 |
........................ 96,886 |
|||
|
15. |
Remittances and items not allocated |
..........................4,618 |
..........................8,233 |
||||
|
16. |
...................................Provision for reinsurance (including $ |
.........................certified) (Schedule F, Part 3, Column 78) |
................................... |
................................... |
|||
|
17. |
...................................................................................Net adjustments in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
||||
|
18. |
.....................................................................................................................................................................Drafts outstanding |
................................... |
................................... |
||||
|
19. |
............................................................................................................................Payable to parent, subsidiaries and affiliates |
...................3,226,940 |
...................5,241,459 |
||||
|
20. |
Derivatives |
................................... |
................................... |
||||
|
21. |
................................................................................................................................................................Payable for securities |
................................... |
................................... |
||||
|
22. |
....................................................................................................................................................Payable for securities lending |
................................... |
................................... |
||||
|
23. |
......................................................................................................................Liability for amounts held under uninsured plans |
................................... |
................................... |
||||
|
24. |
Capital notes $ |
...................................and interest thereon $ |
................................................. |
................................... |
................................... |
||
|
25. |
Aggregate write-ins for liabilities |
||||||
|
26. |
Total liabilities excluding protected cell liabilities (Lines 1 through 25) |
................131,252,340 |
................109,981,387 |
||||
|
27. |
Protected cell liabilities |
||||||
|
28. |
Total liabilities (Lines 26 and 27) |
................131,252,340 |
................109,981,387 |
||||
|
29. |
............................................................................................................................Aggregate write-ins for special surplus funds |
................................... |
................................... |
||||
|
30. |
...............................................................................................................................................................Common capital stock |
...................2,350,000 |
...................2,350,000 |
||||
|
31. |
...............................................................................................................................................................Preferred capital stock |
................................... |
................................... |
||||
|
32. |
...........................................................................................................Aggregate write-ins for other than special surplus funds |
................................... |
................................... |
||||
|
33. |
.............................................................................................................................................................................Surplus notes |
................................... |
................................... |
||||
|
34. |
.......................................................................................................................................Gross paid in and contributed surplus |
...................9,150,000 |
...................9,150,000 |
||||
|
35. |
.......................................................................................................................................................Unassigned funds (surplus) |
................. 13,980,859 |
................. 20,982,308 |
||||
|
36. |
Less treasury stock, at cost: |
||||||
|
36.1 |
shares common (value included in Line 30 |
$ |
) |
................................... |
................................... |
||
|
36.2 |
shares preferred (value included in Line 31 |
$ |
) |
................................... |
................................... |
||
|
37. |
Surplus as regards policyholders (Lines 29 to 35, less 36) (Page 4, Line 39) |
25,480,859 |
32,482,308 |
||||
|
38. |
TOTALS (Page 2, Line 28, Col. 3) |
156,733,199 |
142,463,695 |
||||
|
DETAILS OF WRITE-INS |
|||||||
|
2501 |
.................................... |
||||||
|
2502 |
.................................... |
||||||
|
2503 |
.................................... |
||||||
|
2598. |
Summary of remaining write-ins for Line 25 from overflow page |
.............................................................................................. |
................................... |
................................... |
|||
|
2599. |
Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) |
||||||
|
2901 |
.................................... |
||||||
|
2902 |
.................................... |
||||||
|
2903 |
.................................... |
||||||
|
2998. |
Summary of remaining write-ins for Line 29 from overflow page |
.............................................................................................. |
................................... |
................................... |
|||
|
2999. |
Totals (Lines 2901 thru 2903 plus 2998)(Line 29 above) |
||||||
|
3201. |
...................................................................................................................................................................................................................................... |
.................................... |
3202. ........................................................................................................................................................................................................................................ ....................................
3203. ........................................................................................................................................................................................................................................ ....................................
3298. Summary of remaining write-ins for Line 32 from overflow page .............................................................................................. ................................... ...................................
3299. Totals (Lines 3201 thru 3203 plus 3298)(Line 32 above)
3
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
STATEMENT OF INCOME
|
1 |
2 |
|||
|
Current Year |
Prior Year |
|||
|
UNDERWRITING INCOME |
||||
|
1. |
Premiums earned (Part 1, Line 35, Column 4) |
47,363,903 |
41,901,596 |
|
|
DEDUCTIONS: |
||||
|
2. |
Losses incurred (Part 2, Line 35, Column 7) |
................. 39,133,551 |
................. 32,870,648 |
|
|
3. |
Loss adjustment expenses incurred (Part 3, Line 25, Column 1) |
................... 4,397,225 |
................... 4,327,138 |
|
|
4. |
Other underwriting expenses incurred (Part 3, Line 25, Column 2) |
|||
|
13,802,993 |
11,876,538 |
|||
|
5. |
Aggregate write-ins for underwriting deductions |
........................ 17,806 |
........................ 11,701 |
|
|
6. |
Total underwriting deductions (Lines 2 through 5) |
57,351,575 |
49,086,025 |
|
|
7. |
Net income of protected cells |
................................... |
................................... |
|
|
8. |
Net underwriting gain (loss) (Line 1 minus Line 6 plus Line 7) |
|||
|
................. (9,987,672) |
................. (7,184,429) |
|||
|
INVESTMENT INCOME |
||||
|
9. |
............................................................................Net investment income earned (Exhibit of Net Investment Income, Line 17) |
...................2,056,953 |
................... 1,863,823 |
|
|
10. |
Net realized capital gains (losses) less capital gains tax of $ |
(Exhibit of Capital |
||
|
Gains (Losses) ) |
(730,275) |
(505,910) |
||
|
11. |
Net investment gain (loss) (Lines 9 + 10) |
1,326,678 |
1,357,913 |
|
|
OTHER INCOME |
12. Net gain (loss) from agents' or premium balances charged off (amount recovered
|
$ |
95,829 amount charged off $ |
328,436 |
) |
.....................(232,607) |
.....................(252,079) |
|
|
13. |
...........................................................................................................Finance and service charges not included in premiums |
................................... |
................................... |
|||
|
14. |
Aggregate write-ins for miscellaneous income |
2,314 |
(556) |
|||
|
15. |
..................................................................................................................................Total other income (Lines 12 through 14) |
(230,293) |
(252,635) |
|||
|
16. |
Net income before dividends to policyholders, after capital gains tax and before all other federal and foreign income taxes |
|||||
|
(Lines 8 + 11 + 15) |
................................................................................................................................................................... |
(8,891,287) |
(6,079,152) |
|||
|
17. |
Dividends to policyholders |
27,414 |
39,689 |
|||
|
18. |
Net income, after dividends to policyholders, after capital gains tax and before all other federal and foreign income taxes |
|||||
|
(Line 16 minus Line 17) |
(8,918,701) |
(6,118,841) |
||||
|
19. |
Federal and foreign income taxes incurred |
(1,814,464) |
(1,319,719) |
|||
|
20. |
.......................................................................................................................Net income (Line 18 minus Line 19)(to Line 22) |
(7,104,237) |
(4,799,122) |
|||
|
CAPITAL AND SURPLUS ACCOUNT |
||||||
|
21. |
Surplus as regards policyholders, |
................. 32,482,308 |
................. 37,204,174 |
|||
|
22. |
Net income (from Line 20) |
(7,104,237) |
(4,799,122) |
|||
|
23. |
........................................................................................................................Net transfers (to) from Protected Cell accounts |
................................... |
................................... |
|||
|
24. |
Change in net unrealized capital gains or (losses) less capital gains tax of $ |
(108) |
........................ (3,780) |
..........................2,879 |
||
|
25. |
.................................................................................................Change in net unrealized foreign exchange capital gain (loss) |
.......................... 3,375 |
........................ (1,188) |
|||
|
26. |
...........................................................................................................................................Change in net deferred income tax |
...................... 204,385 |
........................ 68,363 |
|||
|
27. |
Change in nonadmitted assets (Exhibit of Nonadmitted Assets, Line 28, Col. 3) |
|||||
|
..................................................................... |
(101,192) |
7,202 |
||||
|
28. |
................................................................Change in provision for reinsurance (Page 3, Line 16, Column 2 minus Column 1) |
................................... |
................................... |
|||
|
29. |
............................................................................................................................................................Change in surplus notes |
................................... |
................................... |
|||
|
30. |
............................................................................................................Surplus (contributed to) withdrawn from protected cells |
................................... |
................................... |
|||
|
31. |
..............................................................................................................Cumulative effect of changes in accounting principles |
................................... |
................................... |
|||
|
32. |
Capital changes: |
|||||
|
32.1 Paid in |
................................... |
................................... |
||||
|
........................................................................................................................32.2 Transferred from surplus (Stock Dividend) |
................................... |
................................... |
||||
|
.......................................................................................................................................................32.3 Transferred to surplus |
................................... |
................................... |
||||
|
33. |
Surplus adjustments: |
|||||
|
33.1 Paid in |
................................... |
................................... |
||||
|
.............................................................................................................................33.2 Transferred to capital (Stock Dividend) |
................................... |
................................... |
||||
|
....................................................................................................................................................33.3 Transferred from capital |
................................... |
................................... |
||||
|
34. |
.................................................................................................................................Net remittances from or (to) Home Office |
................................... |
................................... |
|||
|
35. |
.........................................................................................................................................................Dividends to stockholders |
................................... |
................................... |
|||
|
36. |
..............................................................Change in treasury stock (Page 3, Lines 36.1 and 36.2, Column 2 minus Column 1) |
................................... |
................................... |
|||
|
37. |
..................................................................................................................Aggregate write-ins for gains and losses in surplus |
|||||
|
38. |
.......................................................................Change in surplus as regards policyholders for the year (Lines 22 through 37) |
(7,001,449) |
(4,721,866) |
|||
|
39. |
Surplus as regards policyholders, |
25,480,859 |
32,482,308 |
|||
|
DETAILS OF WRITE-INS |
||||||
|
0501. |
..............................................................................................................................................................LAD Program - Expense |
........................ 17,806 |
........................ 11,701 |
|||
|
0502 |
.................................... |
|||||
|
0503 |
.................................... |
|||||
|
0598. |
................................................................................................Summary of remaining write-ins for Line 5 from overflow page |
................................... |
................................... |
|||
|
0599. |
Totals (Lines 0501 thru 0503 plus 0598)(Line 5 above) |
17,806 |
11,701 |
|||
|
1401. |
Miscellaneous Income (Loss) |
2,472 |
(454) |
|||
|
1402. |
...................................................................................................................................................................................State Fines and Penalties |
(158) |
............................(102) |
|||
|
1403 |
.................................... |
|||||
|
1498. |
..............................................................................................Summary of remaining write-ins for Line 14 from overflow page |
................................... |
................................... |
|||
|
1499. |
Totals (Lines 1401 thru 1403 plus 1498)(Line 14 above) |
2,314 |
(556) |
|||
|
3701 |
.................................... |
3702. ........................................................................................................................................................................................................................................ ....................................
3703. ........................................................................................................................................................................................................................................ ....................................
3798. Summary of remaining write-ins for Line 37 from overflow page .............................................................................................. ................................... ...................................
3799. Totals (Lines 3701 thru 3703 plus 3798)(Line 37 above)
4
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
CASH FLOW
Cash from Operations
1
Current Year
2
Prior Year
|
1. |
Premiums collected net of reinsurance |
................. 49,381,598 |
................. 42,355,142 |
|
|
2. |
Net investment income |
................... 2,493,749 |
...................2,470,862 |
|
|
3. |
Miscellaneous income |
(194,277) |
(189,871) |
|
|
4. |
Total (Lines 1 through 3) |
51,681,070 |
44,636,133 |
|
|
5. |
Benefit and loss related payments |
................. 35,421,746 |
................. 28,470,000 |
|
|
6. |
.......................................................Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts |
................................... |
................................... |
|
|
7. |
Commissions, expenses paid and aggregate write-ins for deductions |
................. 17,868,513 |
................. 15,724,425 |
|
|
8. |
Dividends paid to policyholders |
........................ 35,663 |
........................ 40,064 |
|
|
9. |
Federal and foreign income taxes paid (recovered) net of $ |
tax on capital gains (losses) |
(1,326,905) |
(384,146) |
|
10. |
Total (Lines 5 through 9) |
51,999,017 |
43,850,343 |
|
|
11. |
Net cash from operations (Line 4 minus Line 10) |
(317,947) |
785,791 |
|
Cash from Investments
12. Proceeds from investments sold, matured or repaid:
|
12.1 |
Bonds |
13,433,166 |
16,369,150 |
|
12.2 |
Stocks |
................................... |
................................... |
|
12.3 |
Mortgage loans |
................................... |
................................... |
|
12.4 |
Real estate |
................................... |
................................... |
|
12.5 |
Other invested assets |
................................... |
................................... |
|
12.6 |
Net gains or (losses) on cash, cash equivalents and short-term investments |
................................... |
............................(689) |
|
12.7 |
Miscellaneous proceeds |
54,853 |
|
|
12.8 Total investment proceeds (Lines 12.1 to 12.7) |
................. 13,488,019 |
................. 16,368,461 |
13. Cost of investments acquired (long-term only):
|
13.1 |
Bonds |
11,141,340 |
15,869,680 |
|
|
13.2 |
Stocks |
................................... |
................................... |
|
|
13.3 |
Mortgage loans |
................................... |
................................... |
|
|
13.4 |
Real estate |
................................... |
................................... |
|
|
13.5 |
Other invested assets |
................................... |
................................... |
|
|
13.6 |
Miscellaneous applications |
247,394 |
||
|
13.7 |
Total investments acquired (Lines 13.1 to 13.6) |
11,141,340 |
16,117,075 |
|
|
14. |
.................................................................................................Net increase/(decrease) in contract loans and premium notes |
|||
|
15. |
Net cash from investments (Line 12.8 minus Line 13.7 minus Line 14) |
2,346,679 |
251,386 |
|
|
Cash from Financing and Miscellaneous Sources |
||||
|
16. |
Cash provided (applied): |
|||
|
16.1 |
Surplus notes, capital notes |
................................... |
................................... |
|
|
16.2 Capital and paid in surplus, less treasury stock |
................................... |
................................... |
||
|
.................................................................................................................................................................16.3 Borrowed funds |
................................... |
................................... |
||
|
..............................................................................16.4 Net deposits on deposit-type contracts and other insurance liabilities |
................................... |
................................... |
||
|
.................................................................................................................................................16.5 Dividends to stockholders |
................................... |
................................... |
||
|
...........................................................................................................................................16.6 Other cash provided (applied) |
(1,963,031) |
(87,501) |
||
|
17. |
Net cash from financing and miscellaneous sources (Lines 16.1 to 16.4 minus Line 16.5 plus Line 16.6) |
(1,963,031) |
(87,501) |
|
|
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS |
||||
|
18. |
........................................Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17) |
65,701 |
949,676 |
|
|
19. |
Cash, cash equivalents and short-term investments: |
|||
|
...............................................................................................................................................................19.1 Beginning of year |
...................2,028,706 |
................... 1,079,030 |
||
|
19.2 End of period (Line 18 plus Line 19.1) |
2,094,407 |
2,028,706 |
Note: Supplemental disclosures of cash flow information for non-cash transactions:
5
Attachments
Disclaimer



December 2023 Erie Insurance Company
December 2023 Flagship City Insurance Company
Advisor News
- Strong underwriting: what it means for insurers and advisors
- Retirement is increasingly defined by a secure income stream
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
More Advisor NewsAnnuity News
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- My Annuity Store Launches a Free AI Annuity Research Assistant Trained on 146 Carrier Brochures and Live Annuity Rates
- Ameritas settles with Navy vet in lawsuit over disputed annuity sale
- NAIC annuity guidance updates divide insurance and advisory groups
- Retirement is increasingly defined by a secure income stream
More Annuity NewsHealth/Employee Benefits News
- Health insurance legislation signed into law by Reynolds
- Researchers from Virginia Commonwealth University Report on Findings in Substance Abuse (Health insurance type moderates the association between substance use disorders and cardiovascular multimorbidity among U.S. adults – Results from the 2023 …): Addiction Research – Substance Abuse
- New Findings from Fudan University Describe Advances in Beta-Lactam Antibiotics (Budget impact analysis of aztreonam-avibactam for metallo-b-lactamase carbapenem-resistant enterobacterales infections in China): Drugs and Therapies – Beta-Lactam Antibiotics
- 4 major class action settlements could put cash in your pocket — See if you qualify
- A LOOK AT NEW OR EXPANDED MEDICAID AND PUBLIC HEALTH PARTNERSHIPS FROM 2025: FINDINGS FROM A SURVEY OF STATE MEDICAID PROGRAMS
More Health/Employee Benefits NewsLife Insurance News
- 5 steps to take before selling your firm
- Bismarck man pleads guilty to taking out insurance policy on dead wife
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- U-Haul Holding Company Schedules Fourth Quarter Fiscal Year End 2026 Financial Results Release and Investor Webcast
- New Empathy and LIMRA Research: The Overlooked Opportunity to Engage the Next Generation After an Insurance Payout
More Life Insurance News